This research aims to develop a novel nanoparticle platform to enhance photodynamic therapy for cervical cancer by addressing tumor hypoxia.
Development of NIR-activated IFHFC nanoparticles
Utilization of dual-mode oxygenation techniques including CAT-catalyzed oxygen generation and PFH oxygen release
Implementation of NIR-I/NIR-II imaging for monitoring efficacy
Enhanced oxygen delivery to tumor sites alleviates hypoxia
Increased production of reactive oxygen species (ROS) promotes more effective photodynamic therapy
Improved imaging capabilities aid in assessing treatment response
Abstract
NIR-activated IFHFC nanoparticles enable NIR-I/NIR-II imaging and dual oxygenation (CAT-catalyzed O 2 generation and PFH O 2 release), relieving hypoxia and boosting ROS for enhanced PDT.
Demander à l'IA
Like
Bookmark
Share
View Full Paper
Demander à l'IA
Like
Bookmark
Share
View Full Paper
NIR-activated dual-mode oxygen-generating and -delivering nanoplatform for enhanced photodynamic therapy of cervical cancer | Synapse